Clinical Trials on Progesterone Receptor- Negative Breast Cancer
Total 11771 results
-
Massachusetts General HospitalNational Cancer Institute (NCI); Federal Share CoreWithdrawnBreast CancerUnited States
-
Ottawa Hospital Research InstituteCompleted
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
PfizerAstellas Pharma Inc; Medivation, Inc.Withdrawn
-
Genentech, Inc.SOLTI Breast Cancer Research GroupCompletedBreast CancerUnited States, Spain, Portugal
-
Mario Negri Institute for Pharmacological ResearchTerminatedTriple Negative Breast CancerSpain, Italy, Portugal
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, United Kingdom, France, United States, Denmark, Hong Kong
-
Instituto Nacional de Cancer, BrazilCompletedTriple Negative Breast Cancer | Triple Negative Breast NeoplasmsBrazil
-
Clinica Universidad de Navarra, Universidad de...Unknown
-
CASI Pharmaceuticals, Inc.University of Colorado, Denver; Indiana University Melvin and Bren Simon Cancer...CompletedTriple Negative Breast CancerUnited States, China
-
China Breast Cancer Clinical Study GroupUnknown
-
SanofiBreast Cancer Research FoundationCompletedTriple Negative Breast CancerUnited States
-
Russian Academy of Medical SciencesRussian Society of Clinical OncologyUnknownTriple Negative Breast Cancer
-
Fudan UniversityUnknown
-
Thomas Jefferson UniversityUnknownBreast CancerUnited States
-
Nippon Kayaku Co., Ltd.CompletedTriple Negative Breast CancerUnited States
-
Severance HospitalUnknown
-
Baylor Breast Care CenterM.D. Anderson Cancer CenterTerminatedBreast CancerUnited States
-
M.D. Anderson Cancer CenterNational Institutes of Health (NIH)Withdrawn
-
UNC Lineberger Comprehensive Cancer CenterBellicum PharmaceuticalsNot yet recruitingBreast Cancer | Triple Negative Breast Cancer | Relapse | Resistant CancerUnited States
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
Miguel Martín JiménezUNC Lineberger Comprehensive Cancer Center; Hospital Universitario Ramon y... and other collaboratorsActive, not recruitingBreast Cancer | Breast Cancer Stage II-IIISpain
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingEarly-stage Triple-negative Breast Cancer With BRCA1/2 MutationsChina
-
Hubei Cancer HospitalNot yet recruiting
-
Regina Elena Cancer InstituteFondazione Policlinico Universitario Agostino Gemelli IRCCS; Catholic University... and other collaboratorsRecruiting
-
Ourotech, Inc.Barts & The London NHS Trust; Imperial College Healthcare NHS Trust; Hampshire... and other collaboratorsRecruitingBreast Cancer | Triple Negative Breast CancerUnited Kingdom
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingTriple Negative Breast CancerUnited States
-
Vall d'Hebron Institute of OncologyRecruitingTriple Negative Breast CancerSpain
-
Fudan UniversityRecruitingBreast Cancer | Triple Negative Breast CancerChina
-
Power Life Sciences Inc.Not yet recruitingBreast Cancer | Triple Negative Breast Cancer
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
M.D. Anderson Cancer CenterGilead SciencesRecruiting
-
Sun Yat-sen UniversityRecruitingTriple Negative Breast CancerChina
-
Ourotech, Inc.Barts & The London NHS TrustRecruitingTriple Negative Breast Cancer | Triple Negative Breast NeoplasmsUnited Kingdom
-
Nova Scotia Health AuthorityObafemi Awolowo UniversityNot yet recruitingTriple Negative Breast Cancer
-
University of Alabama at BirminghamNot yet recruitingTriple Negative Breast CancerUnited States
-
Sun Yat-sen UniversityRecruitingTriple Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
University of Illinois at ChicagoRecruitingTriple Negative Breast CancerUnited States
-
Shengjing HospitalRecruiting
-
European Institute of OncologyRecruitingTriple Negative Breast CancerItaly
-
Zenith EpigeneticsPfizer; Newsoara Biopharma Co., Ltd.TerminatedTriple Negative Breast CancerUnited States, Belgium, China, Spain
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Ayala Pharmaceuticals, Inc,TerminatedTriple Negative Breast CancerUnited States, Belgium, Israel, Spain, United Kingdom
-
Jeong Eon LeeAsan Medical Center; Seoul National University Hospital; Gangnam Severance Hospital and other collaboratorsActive, not recruiting
-
Fudan UniversityActive, not recruitingTA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA SignatureBreast Cancer | Triple Negative Breast CancerChina
-
Tata Memorial HospitalActive, not recruiting
-
Hoffmann-La RocheBreast International Group; Frontier Science & Technology Research Foundation... and other collaboratorsCompletedTriple Negative Breast CancerRussian Federation, United States, Israel, Italy, Spain, France, Korea, Republic of, United Kingdom, Denmark, Taiwan, Hungary, Argentina, Australia, Austria, Belgium, Brazil, China, Germany, Hong Kong, Japan, Mexico, Romania, Switze... and more